Adjuvants to mechanical ventilation for acute respiratory FailureL: Adoption, de-adoption, and factors associated with selection

Annals of the American Thoracic Society

Volumn 14, Issue 1, 2017, Pages 94-102

  Munshi, Laveena ^a   Gershengorn, Hayley B ^b   Fan, Eddy ^a   Wunsch, Hannah ^c   Ferguson, Niall D ^a   Stukel, Therese A ^d   Rubenfeld, Gordon D ^c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Acute respiratory distress syndrome; Epoprostenol; Extracorporeal membrane oxygenation; Neuromuscular blockade; Nitric oxide

Indexed keywords

ATRACURIUM BESILATE; CISATRACURIUM; DOXACURIUM; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; NITRIC OXIDE; PANCURONIUM; PROSTACYCLIN; ROCURONIUM; VASODILATOR AGENT; VECURONIUM; ANTIHYPERTENSIVE AGENT; BRONCHODILATING AGENT;

ACUTE RESPIRATORY FAILURE; ADOPTION; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL EVALUATION; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EXTRACORPOREAL OXYGENATION; FEMALE; HOSPITAL CARE; HOSPITAL CHARGE; HUMAN; ICD-9; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; TIME TO TREATMENT; VENTILATED PATIENT; ACUTE DISEASE; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; NEUROMUSCULAR BLOCKING; PROCEDURES; RESPIRATORY FAILURE; TRENDS;

ACUTE DISEASE; ADMINISTRATION, INHALATION; AGED; ANTIHYPERTENSIVE AGENTS; BRONCHODILATOR AGENTS; COHORT STUDIES; EPOPROSTENOL; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NITRIC OXIDE; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES;

EID: 85008400018     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201606-438OC     Document Type: Article

References (39)

1. Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, et al.; LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016;315: 788-800.
2. Bell N, Hutchinson CL, Green TC, Rogan E, Bein KJ, Dinh MM. Randomised control trial of humidified high flow nasal cannulae versus standard oxygen in the emergency department. Emerg Med Australas [online ahead of print] 29 Sep 2015; DOI: 10.1111/1742-6723.12490.
3. Gúerin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, Mercier E, Badet M, Mercat A, Baudin O, et al.; PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013;368:2159-2168.
4. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N, et al.; CESAR Trial Collaboration. Efficacy and economic assessment of Conventional Ventilatory Support versus Extracorporeal Membrane Oxygenation for Severe Adult Respiratory Failure (CESAR): a multicentre randomised controlled trial. Lancet 2009;374:1351-1363.
5. Pham T, Combes A, Rozé H, Chevret S, Mercat A, Roch A, Mourvillier B, Ara-Somohano C, Bastien O, Zogheib E, et al.; REVA Research Network. Extracorporeal membrane oxygenation for pandemic influenza A (H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis. Am J Respir Crit Care Med 2013;187:276-285.
6. Noah MA, Peek GJ, Finney SJ, Griffiths MJ, Harrison DA, Grieve R, Sadique MZ, Sekhon JS, McAuley DF, Firmin RK, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A (H1N1). JAMA 2011;306: 1659-1668.
7. Ferguson ND, Cook DJ, Guyatt GH, Mehta S, Hand L, Austin P, Zhou Q, Matte A, Walter SD, Lamontagne F, et al.; OSCILLATE Trial Investigators; Canadian Critical Care Trials Group. High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med 2013;368:795-805.
8. Young D, Lamb SE, Shah S, MacKenzie I, Tunnicliffe W, Lall R, Rowan K, Cuthbertson BH; OSCAR Study Group. High-frequency oscillation for acute respiratory distress syndrome. N Engl J Med 2013;368:806-813.
9. Steingrub JS, Lagu T, Rothberg MB, Nathanson BH, Raghunathan K, Lindenauer PK. Treatment with neuromuscular blocking agents and the risk of in-hospital mortality among mechanically ventilated patients with severe sepsis. Crit Care Med 2014;42:90-96.
10. Adhikari NK, Burns KE, Friedrich JO, Granton JT, Cook DJ, Meade MO. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ 2007;334:779.
11. Beitler JR, Goligher EC, Schmidt M, Spieth PM, Zanella A, Martin-Loeches I, Calfee CS, Cavalcanti AB; ARDSne(x)t Investigators. Personalized medicine for ARDS: the 2035 research agenda. Intensive Care Med 2016;42:756-767.
12. Premier Research Services. Premier Perspective hospital database. Charlotte, NC: Premier, Inc.; April 2014.
13. Thomsen GE, Morris AH. Incidence of the adult respiratory distress syndrome in the state of Utah. Am J Respir Crit Care Med 1995;152: 965-971.
14. Angus D, Linde-Zwirlbl W, Clermont G, Newbold R, Pinsky M. What's the incidence and mortality of ARDS in the US? [abstract]. Am J Respir Crit Care Med 1996;153:A592.
15. Reynolds HN, McCunn M, Borg U, Habashi N, Cottingham C, Bar-Lavi Y. Acute respiratory distress syndrome: estimated incidence and mortality rate in a 5 million-person population base. Crit Care 1998;2: 29-34.
16. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307: 2526-2533.
17. Maxell BG, Powers AJ, Sheikh AY, Lee PH, Lobato RL, Wong JK. Resource use trends in extracorporeal membrane oxygenation in adults: an analysis of the Nationwide Inpatient Sample 1998-2009. J Thorac Cardiovasc Surg 2014;148:416-421.e1.
18. Lexicomp Online. Lexi-Drugs. Hudson, OH: Lexi-Comp, Inc; April 2014.
19. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27.
20. McCullagh P. Generalized linear models. New York: Chapman & Hall; 1989.
21. You JJ, Alter DA, Stukel TA, McDonald SD, Laupacis A, Liu Y, Ray JG. Proliferation of prenatal ultrasonography. CMAJ 2010;182: 143-151.
22. Alter DA, Stukel TA, Newman A. Proliferation of cardiac technology in Canada: a challenge to the sustainability of Medicare. Circulation 2006;113:380-387.
23. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002;27:299-309.
24. Afshari A, Brok J, Møller A, Wetterslev J. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults. Cochrane Database Syst Rev 2010;7:CD002787.
25. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez D, Seghboyan JM, et al.; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;363:1107-1116.
26. Schmidt M, Bailey M, Sheldrake J, Hodgson C, Aubron C, Rycus PT, Scheinkestel C, Cooper DJ, Brodie D, Pellegrino V, et al. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure: the Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med 2014;189:1374-1382.
27. Wiener RS, Welch HG. Trends in the use of the pulmonary artery catheter in the United States, 1993-2004. JAMA 2007;298:423-429.
28. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending. 2. Health outcomes and satisfaction with care. Ann Intern Med 2003; 138:288-298.
29. Gershengorn HB, Wunsch H. Understanding changes in established practice: pulmonary artery catheter use in critically ill patients. Crit Care Med 2013;41:2667-2676.
30. Dushianthan A, Cusak R, Chee J, Dunn J, Grocott M. Perceptions of diagnosis and management of patients with acute respiratory distress syndrome: a survey of UK intensive care physicians. BMC Anesthesiol 2014;14:87-95.
31. KredelM, BierbaumD, Lotz C, Küstermann J, Roewer N, Muellenbach RM. [Therapy of acute respiratory distress syndrome: survey of German ARDS centers and scientific evidence] [article in German]. Anaesthesist 2015;64:277-285.
32. Walkey AJ, Wiener RS. Utilization patterns and patient outcomes associated with use of rescue therapies in acute lung injury. Crit Care Med 2011;39:1322-1328.
33. Jonsen AR. Bentham in a box: technology assessment and health care allocation. Law Med Health Care 1986;14:172-174.
34. Slutsky AS. Neuromuscular blocking agents in ARDS. N Engl J Med 2010;363:1176-1180.
35. Niven DJ, Rubenfeld GD, Kramer AA, Stelfox HT. Effect of published scientific evidence on glycemic control in adult intensive care units. JAMA Intern Med 2015;175:801-809.
36. Rubenfeld GD. Understanding why we agree on the evidence but disagree on the medicine. Respir Care 2001;46:1442-1449.
37. Alhurani RE, Oeckler RA, Franco PM, Jenkins SM, Gajic O, Pannu SR; National Survey of Adult Intensivists. Refractory hypoxemia and use of rescue strategies. Ann Am Thorac Soc 2016;13:1105-1114.
38. Kahn JM, Le TQ. Adoption and de-adoption of drotrecogin alfa for severe sepsis in the United States. J Crit Care 2016;32:114-119.
39. Weinert CR, Gross CR, Marinelli WA. Impact of randomized trial results on acute lung injury ventilator therapy in teaching hospitals. Am J Respir Crit Care Med 2003;167:1304-1309.